Fundamental Analysis
100 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +111.5% | +89.6% | 3 / 3 | +35.6% | +4.78 pp | +7.78 pp | +21.0% | 0.01 | 5.88 | 42,1 | +35,6% | 9,1 | +111,5% | 5.88 | 7.90 | −25,6% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 19.800 (close price on 2026-10-19)EPS (TTM): 3.370
Financial charts
1.Revenue & growth
VND bn42,1Q2/26
1.Revenue & growth
VND bn42,1Q2/26
2.Profit & growth
VND bn9,13Q2/26
3.Profit mix (Penman)
VND bn37,1Q2/26
4.Margins & cost structure
%37.8%Q2/26
5.Returns & cash cycle
% · days23.3%Q2/26
6.Earnings quality & cash
VND bn29,9Q2/26
7.Asset structure
VND bn180Q2/26
8.Funding & debt health
VND bn · times180Q2/26
9.Revenue backlog
VND bn7,55Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.038Q2/26
Adjusted EPS growth, latest quarter
111%
Average adjusted EPS growth, 3 quarters
89.6%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26